Cureus

Long-term COVID-19 symptoms 12 months after hospital stay in Colombian patients

Updated

Abstract

The prevalence of post-acute sequelae of SARS-CoV-2 infection (PASC) at 12 months among hospitalized COVID-19 patients was 40.7%.

  • Female sex and markers of severe acute disease are associated with persistent PASC at 12 months.
  • Patients with PASC at six months are more likely to experience persistence of symptoms at 12 months.
  • High vaccination coverage was observed at follow-up, with more adverse reactions reported among patients with PASC.
  • No differences in PASC development were found based on the vaccine platform used.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Research Ethics Committee of Fundación Oftalmológica de Santander (FOSCAL) issued approval 03361/2020. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free